Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Non-cystic fibrosis bronchiectasis: Etiologic approach and effects of long-term azithromycin in children

Ayse Ayzit Kilinc, Haluk Cokugras.




Abstract
Cited by 0 Articles

Aim: Non-cystic fibrosis bronchiectasis (NCFB) is a chronic pulmonary problem that includes a group of heterogeneous diseases. Macrolide antibiotics are increasingly prescribed for patients with NCFB, but there are very few studies on their use in children. This study aimed to search the clinical features of children with NCFB and the effect of long-term use of azithromycin on the frequency of aggravation, microbiological reproduction, and pulmonary function tests.
Materials and Methods: A total of 79 cases diagnosed with NCFB were recorded. Clinical, laboratory, and radiological evaluations were also recorded. Exacerbation frequency, sputum cultures, and pulmonary function tests of 27 children who received azithromycin before and during prophylaxis were also analyzed.
Results: The median age of children was 7.6 years old (1 to 16 years), when the children were diagnosed with NCFB. Bronchiectasis etiology was detected in 62 patients. Primary ciliary dyskinesia (PCD) was the most common cause of bronchiectasis, which 24 (30%) children were diagnosed with PCD. Azithromycin treatment was given to 27 bronchiectasis patients for six months. A statistically significant decrease was detected in pulmonary aggravation frequency and sputum microbiology during azithromycin treatment (p < 0.01). No significant difference was detected in the pulmonary function tests with azithromycin treatment (p > 0.05)
Conclusion: The use of azithromycin in children with NCFB improves aggravation frequency but has no significant effect on the pulmonary function test.

Key words: Azithromycin; non-cystic fibrosis bronchiectasis; primary ciliary dyskinesia; pulmonary exacerbation






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.